243 related articles for article (PubMed ID: 33340241)
1. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
[TBL] [Abstract][Full Text] [Related]
2. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
3. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
[TBL] [Abstract][Full Text] [Related]
4. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced PINK1/Parkin-mediated mitophagy promotes pulmonary vascular remodeling.
Linqing L; Yuhan Q; Erfei L; Yong Q; Dong W; Chengchun T; Gaoliang Y; Bo L
Biochem Biophys Res Commun; 2021 Jan; 534():568-575. PubMed ID: 33239167
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration.
Song JL; Zheng SY; He RL; Gui LX; Lin MJ; Sham JSK
Vascul Pharmacol; 2021 Jun; 138():106860. PubMed ID: 33794383
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Pulmonary Vascular Remodeling in Hypoxia: Role of 15-LOX-2/15-HETE-MAPKs Pathway.
Yu X; Li T; Liu X; Yu H; Hao Z; Chen Y; Zhang C; Liu Y; Li Q; Mao M; Zhu D
Cell Physiol Biochem; 2015; 35(6):2079-97. PubMed ID: 25895668
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
9. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
10. GPR146 regulates pulmonary vascular remodeling by promoting pulmonary artery smooth muscle cell proliferation through 5-lipoxygenase.
Huang J; Xie Y; Chen B; Xia Y; Jiang Y; Sun Z; Liu Y
Eur J Pharmacol; 2023 Dec; 961():176123. PubMed ID: 37926274
[TBL] [Abstract][Full Text] [Related]
11. Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration.
You B; Liu Y; Chen J; Huang X; Peng H; Liu Z; Tang Y; Zhang K; Xu Q; Li X; Cheng G; Shi R; Zhang G
Cardiovasc Res; 2018 Jan; 114(1):188-199. PubMed ID: 29186367
[TBL] [Abstract][Full Text] [Related]
12. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
[TBL] [Abstract][Full Text] [Related]
13. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
[TBL] [Abstract][Full Text] [Related]
14. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
[No Abstract] [Full Text] [Related]
15. HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.
Wang J; Tian XT; Peng Z; Li WQ; Cao YY; Li Y; Li XH
Vascul Pharmacol; 2019 Jun; 117():35-44. PubMed ID: 30610955
[TBL] [Abstract][Full Text] [Related]
16. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
17. Influence of 2-Methoxyestradiol and Sex on Hypoxia-Induced Pulmonary Hypertension and Hypoxia-Inducible Factor-1-α.
Docherty CK; Nilsen M; MacLean MR
J Am Heart Assoc; 2019 Mar; 8(5):e011628. PubMed ID: 30819028
[TBL] [Abstract][Full Text] [Related]
18. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
19. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
[TBL] [Abstract][Full Text] [Related]
20. Bioactive Compounds From Coptidis Rhizoma Alleviate Pulmonary Arterial Hypertension by Inhibiting Pulmonary Artery Smooth Muscle Cells' Proliferation and Migration.
Luo S; Kan J; Zhang J; Ye P; Wang D; Jiang X; Li M; Zhu L; Gu Y
J Cardiovasc Pharmacol; 2021 Aug; 78(2):253-262. PubMed ID: 34554677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
